Menu
Search
|

Menu

Close
X

Pfizer Inc PFE.N (New York Stock Exchange)

42.77 USD
-0.29 (-0.67%)
As of Jul 19
Previous Close 43.06
Open 43.17
Volume 4,516,004
3m Avg Volume 6,542,794
Today’s High 43.19
Today’s Low 42.77
52 Week High 46.46
52 Week Low 37.12
Shares Outstanding (mil) 5,955.13
Market Capitalization (mil) 214,682.30
Forward P/E 26.26
Dividend (Yield %) 0.32 ( 3.55 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.36 Mean rating from 14 analysts

KEY STATS

Revenue (mm, USD)
FY19
13,118
FY18
53,647
FY17
52,546
FY16
52,825
EPS (USD)
FY19
0.675
FY18
1.719
FY17
1.965
FY16
1.178
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
26.26
32.67
Price to Sales (TTM)
vs sector
4.10
7.92
Price to Book (MRQ)
vs sector
3.67
5.39
Price to Cash Flow (TTM)
vs sector
14.86
24.37
Total Debt to Equity (MRQ)
vs sector
74.88
14.56
LT Debt to Equity (MRQ)
vs sector
58.58
10.21
Return on Investment (TTM)
vs sector
6.00
14.49
Return on Equity (TTM)
vs sector
13.80
15.79

EXECUTIVE LEADERSHIP

Ian Read
Executive Chairman of the Board, Since 2018
Salary: $1,992,500.00
Bonus: $3,000,000.00
Albert Bourla
Chief Executive Officer, Director, Since 2018
Salary: $1,400,000.00
Bonus: $1,533,000.00
Frank D'Amelio
Chief Financial Officer, Executive Vice President - Business Operations, Since 2010
Salary: $1,407,920.00
Bonus: $1,310,000.00
Mikael Dolsten
President - Worldwide Research and Development, Since 2010
Salary: $1,306,250.00
Bonus: $1,326,000.00
Michael Goettler
Group President - Pfizer Upjohn, Since 2019
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

235 E 42ND ST
NEW YORK   NY   10017-5703

Phone: +1212.5732323

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

SPONSORED STORIES